Becton Dickinson

Strategic Intent

Becton Dickinson (BD) is a global medical technology company that develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products to improve clinical discovery and healthcare delivery.

Key Market Signals

• 2025-11: Announced planned combination of Biosciences and Diagnostic Solutions business with Waters Corporation by Q1 2026
• 2025-01: CISA issued advisory for high-severity vulnerability (CVE-2024-10476) in BD Diagnostic Solutions products
• 2024-12: Settled SEC investigation into Alaris infusion pump disclosure failures for $175 million
• 2024-10: Agreed to a global resolution of approximately 38,000 hernia mesh product liability claims
• 2024-09: Completed $4.2 billion acquisition of Edwards Lifesciences' Critical Care product group

Financial Health

• Reported FY2025 revenue of $21.8 billion, representing an 8.2% increase over the previous year (Source: https://www.tradingview.com/news/reuters.com,2025-11-06:newsml_nBw9X05Ga:0/)
• Maintains a strong cash flow position, returning $2.2 billion to shareholders through dividends and share repurchases in fiscal 2025 (Source: https://www.bd.com/en-us/company/investors/financial-reports/earnings-releases/2025/bd-reports-fourth-quarter-and-full-year-fiscal-2025-financial-results)
• Completed a $4.2 billion cash acquisition of Edwards Lifesciences' Critical Care business in September 2024, funded by $1 billion cash and $3.2 billion new debt (Source: https://www.pharmexec.com/view/bd-to-acquire-edwards-lifesciences-critical-care-product-group-for-4-2-billion)

Impact & Compliance

Legal & Risks

BD faces significant legal and regulatory risks, recently settling a $175 million SEC penalty for misleading investors and reaching a confidential global resolution for approximately 38,000 hernia mesh lawsuits.

Forensic Audit — 2 findings

• SEC penalty of $175 million for violating antifraud, reporting, and internal accounting controls provisions
• Established a $1.9 billion reserve for product liability cases, primarily related to hernia mesh litigation

Classifications

Proprietary Analysis